Efficacy and Safety of the Absorb Bioresorbable Vascular Scaffold in Females and Males-Reference-Cited by-同舟云学术

Efficacy and Safety of the Absorb Bioresorbable Vascular Scaffold in Females and Males

Published:2017-09 Issue:18 Volume:10 Page:1881-1890
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Shreenivas Satya,Kereiakes Dean J.,Ellis Stephen G.,Gao Runlin,Kimura Takeshi,Onuma Yoshinobu,Piard-Ruster Karine,Zhang Yunlong,Koo Kai,Vu Minh-Thien,Serruys Patrick W.,Stone Gregg W.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference22 articles.

1. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies;Kirtane;Circulation,2009

2. Coronary-artery stents;Serruys;N Engl J Med,2006

3. Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis;Palmerini;J Am Coll Cardiol,2015

4. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk;Joner;J Am Coll Cardiol,2006

5. Evaluation of a fully bioresorbable vascular scaffold in patients with coronary artery disease: design of and rationale for the ABSORB III randomized trial;Kereiakes;Am Heart J,2015

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Negative findings but positive contributions in cardiovascular research;Life Sciences;2023-08

2. Sex Differences in the Clinical Features and Outcomes of Patients with Acute Coronary Syndrome Treated with Two Generations (Absorb and Magmaris) of Bioresorbable Vascular Scaffolds;Journal of Clinical Medicine;2021-08-24

3. Evolución de pacientes tratados con armazones coronarios bioabsorbibles liberadores de everolimus tras su disolución completa;Revista Española de Cardiología;2021-07

4. Outcomes after complete dissolution of everolimus-eluting bioresorbable scaffolds implanted during routine practice;REV ESP CARDIOL;2021

5. Outcomes after complete dissolution of everolimus-eluting bioresorbable scaffolds implanted during routine practice;Revista Española de Cardiología (English Edition);2021-07